Dupilumab as a novel steroid-sparing treatment for IgG4-related disease

Volume: 79, Issue: 4, Pages: 549 - 550
Published: Dec 19, 2019
Abstract
IgG4-related disease (IgG4-RD) is a rare fibroinflammatory, multisystemic condition with a relapsing-remitting progression.1 The level of serum IgG4 correlates with inflammatory activity and organ involvement.1 Glucocorticoids are first line for IgG4-RD, but there are numerous adverse effects with chronic use.2 Dupilumab is a monoclonal antibody that acts on the interleukin 4 (IL-4) receptor alpha, shared by the IL-4 and IL-13 receptors.1 IL-4...
Paper Details
Title
Dupilumab as a novel steroid-sparing treatment for IgG4-related disease
Published Date
Dec 19, 2019
Volume
79
Issue
4
Pages
549 - 550
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.